戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 h from respiratory failure and infections in infantiles.
2       Study paediatricians collected data on infantile AD at repeated follow-up examinations during t
3   Unlike established AD, these patients with infantile AD did not have noticeably dysbiotic communiti
4                       Like CF, DMD, SMA, and infantile AMD are inexorably debilitating and require li
5                   It has been suggested that infantile amnesia is due to the underdevelopment of the
6 hat in rats an experience learned during the infantile amnesia period is stored as a latent memory tr
7                              We propose that infantile amnesia reflects a developmental critical peri
8 re rapidly forgotten, a phenomenon known as 'infantile amnesia'.
9                                              Infantile amnesia, the inability of adults to recollect
10 ined in rats that illuminates the paradox of infantile amnesia.
11 ng BDNF or mGluR5 after training rescues the infantile amnesia.
12                                 Early onset (infantile and childhood) phenotypes likely represent dev
13 cid position were found in both variant late infantile and Kufs disease.
14 sidered as a differential diagnosis for both infantile- and juvenile-onset movement disorders, includ
15                               Results of the Infantile Aphakia Treatment Study have concluded that pr
16  rate of adverse events than reported in the Infantile Aphakia Treatment Study.
17 intake during pregnancy and breastfeeding to infantile asthma phenotypes and elevated IgE level.
18                     Patients with persistent infantile atopic dermatitis are more likely to develop a
19                     Of the 246 patients with infantile atopic dermatitis at 6 months of age, 48 patie
20 lowed until 6 years of age; 246 patients had infantile atopic dermatitis at 6 months of age.
21                     Patients with persistent infantile atopic dermatitis had a higher risk of asthma
22      Risk factors associated with persistent infantile atopic dermatitis included egg white sensitiza
23 s of age were associated with the persistent infantile atopic dermatitis.
24 e risk factors related to the persistence of infantile atopic dermatitis.
25 tum was associated with an increased risk of infantile atopic eczema at age 12 months, but no signifi
26      Within the UK Southampton Women Survey, infantile atopic eczema at ages 6 and 12 months was asce
27 y (n = 497) and related to the odds ratio of infantile atopic eczema.
28 antile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease) is a neurodegenerative lysosom
29 fied fish sauce has the potential to prevent infantile beriberi in this population.
30                                  Importance: Infantile beriberi, a potentially fatal disease caused b
31 al virus (RSV) is the most frequent cause of infantile bronchiolitis and pneumonia.
32  described in patients presenting with fatal infantile cardiomyopathy and multiple oxidative phosphor
33  described patients with AARS2-related fatal infantile cardiomyopathy are united by either a homozygo
34  of two unrelated boys presenting with fatal infantile cardiomyopathy, lactic acidosis and respirator
35           Severe ocular alterations occur in infantile cases, whereas mild or no ocular alterations a
36 on for unilateral or bilateral congenital or infantile cataract in children younger than 2 years of a
37 ciated with profound developmental delay and infantile cataract.
38 mans, has been known to cause congenital and infantile cataracts.
39 rkably, is also responsible for variant late infantile ceroid lipofuscinosis.
40   Patients and mutations were separated into infantile, childhood and adult-onset groups.
41           Patients were divided into classic infantile, childhood-onset, and adult-onset patients.
42      We found that (i) encephalopathies with infantile/childhood onset epilepsies (>/=3 months of age
43  kinesigenic dyskinesia (38.7%; n = 560) and infantile convulsions and choreoathetosis (14.3%; n = 20
44 nts with benign familial infantile epilepsy, infantile convulsions and choreoathetosis and paroxysmal
45 inesia (PKD), and their combination-known as infantile convulsions and paroxysmal choreoathetosis (IC
46 pinal cord motor neurons, muscle atrophy and infantile death or severe disability.
47 disease that is the leading genetic cause of infantile death.
48 that can cause hemolytic uremic syndrome and infantile diarrhea, respectively.
49                     Only 6 patients with non-infantile disease (11%, all with end-stage renal disease
50 the MA ion channel TMEM63A that result in an infantile disorder resembling a hypomyelinating leukodys
51 pamine transporter (DAT) cause a syndrome of infantile dystonia/parkinsonism.
52 presynaptic membrane-fusion machinery, cause infantile early epileptic encephalopathy (Ohtahara syndr
53 multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 popu
54 logy 'childhood eczema', 'flexural eczema', 'infantile eczema', 'atopic neurodermatitis', or 'Besnier
55 ion was associated with an increased risk of infantile eczema, childhood wheeze/asthma, eczema and al
56 show that probiotic supplementation prevents infantile eczema, thus suggesting a new potential indica
57                                              Infantile encephalopathies are a group of clinically and
58                                        Early-infantile encephalopathies with epilepsy are devastating
59 rs that comprise approximately 10% of static infantile encephalopathies.
60  affected by a remarkably similar phenotype (infantile encephalopathy and largely normal brain MRI) t
61   We identified two additional patients with infantile encephalopathy and partially overlapping clini
62 cluding the recently described NALCN-related infantile encephalopathy, is increasingly recognized.
63 y normal brain MRI) to that of NALCN-related infantile encephalopathy, we identified a locus on 2q34
64 ional and regional incidence of neonatal and infantile endogenous endophthalmitis and comorbidities a
65 risk factors for development of neonatal and infantile endogenous endophthalmitis.
66     In 2007, an estimated 291 total cases of infantile endophthalmitis were identified, in comparison
67 on or seizure freedom in children with early infantile epilepsies (<3 months), whereas other antiepil
68                              Benign familial infantile epilepsy (41.7%; n = 602), paroxysmal kinesige
69  dystonia at 3 years, and L924P, with severe infantile epilepsy and profound impairment.
70 ction mutations in KCC2 are a known cause of infantile epilepsy in humans and KCC2 dysfunction is pre
71 suggest that mutations associated with early infantile epilepsy result in increased sodium channel ac
72        Infantile spasms constitutes a severe infantile epilepsy syndrome that is difficult to treat a
73 e promoter of CDKL5, a gene causative for an infantile epilepsy, from the silenced X-chromosomal alle
74 he majority of patients with benign familial infantile epilepsy, infantile convulsions and choreoathe
75                          Patients with early infantile epileptic encephalopathy (EIEE) are at increas
76                          Patients with early infantile epileptic encephalopathy (EIEE) experience sev
77  defects and epileptic phenotypes, including infantile epileptic encephalopathy (EIEE), suggestive of
78                                        Early infantile epileptic encephalopathy (EIEE)-associated mut
79 ve mutation of TBC1D24 associated with early infantile epileptic encephalopathy (EIEE).
80               SCN8A encephalopathy, or early infantile epileptic encephalopathy 13 (EIEE13), is cause
81 ion and present with developmental and early infantile epileptic encephalopathy that is far more seve
82 ated sodium channel gene are linked to early-infantile epileptic encephalopathy type 13, also known a
83 uals described here, however, cause a severe infantile epileptic encephalopathy with a central myelin
84 HO-like, and there is an overlap with 'early infantile epileptic encephalopathy'.
85 ed individuals with congenital microcephaly, infantile epileptic encephalopathy, and profound develop
86 ngs and an unrelated individual) with severe infantile epileptic encephalopathy, clubfoot, absent dee
87  behavioural disorders, and 14 patients with infantile epileptic encephalopathy, of which 13 had seve
88  deficiency leads to potentially fatal early infantile epileptic encephalopathy, severe developmental
89       SCN8A is a novel causal gene for early infantile epileptic encephalopathy.
90 ndrome, autism spectrum disorders, and early infantile epileptic encephalopathy.
91      Mutations in the SCN8A gene cause early infantile epileptic encephalopathy.
92 ts, often manifesting as treatment-resistant infantile epileptic encephalopathy.
93                                 Menkes is an infantile, fatal, hereditary copper-deficiency disorder
94 TRK3 with various partners are diagnostic of infantile fibrosarcoma and secretory carcinoma yet also
95 st universally harbor TRK fusions, including infantile fibrosarcoma, cellular congenital mesoblastic
96 osomal recessive ataxia type-1 (SPARCA1), an infantile form of ataxia with cognitive impairment.
97                 Compared to the variant late infantile form, there was a lower proportion of variants
98 ilinear profiles, which are seen in the late infantile form, were not a feature.
99                       One of the more severe infantile forms of the disease (INCL or CLN1 disease) is
100 of rectal bleeding in infants, while classic infantile FPE is rarely diagnosed.
101 ated sweat chloride, recurrent hyponatremia, infantile FTT and lung disease identified deleterious va
102 , two children with elevated sweat chloride, infantile FTT, and recurrent hyponatremia were homozygou
103 inal muscular atrophy (SMA) is a devastating infantile genetic disorder caused by the loss of surviva
104                                              Infantile globoid cell leukodystrophy (GLD, Krabbe disea
105 al characteristics resembling those noted in infantile GM2 gangliosidosis has been described.
106 dications for treatment are life-threatening infantile haemangioma (causing heart failure or respirat
107                   With a prevalence of 4.5%, infantile haemangiomas are the most common benign tumour
108                                         Most infantile haemangiomas do not require therapy.
109 rdant regulation was also conserved in human infantile hearts.
110 (3 mg/kg/day) in the treatment of periocular infantile hemangioma (IH) based on clinical and radiolog
111                                              Infantile hemangioma (IH) is the most common tumor of in
112 stly, in a patient-derived in vitro model of infantile hemangioma and pre-clinical model of HLTRS we
113 es of these lesions are shared with those of infantile hemangioma and tufted angioma of children, but
114                                              Infantile hemangioma is the most common benign vascular
115 220 parents/caregivers completed the 35-item Infantile Hemangioma Quality-of-Life (IH-QoL) instrument
116 hat EndMT induced by M1 macrophages promotes infantile hemangioma regression and may lead to novel th
117 ants 1 to 5 months of age with proliferating infantile hemangioma requiring systemic therapy.
118 common, predominantly benign complication in infantile hemangioma, little is known about the prognosi
119 e pathogenic C482R VEGFR-2 mutant, linked to infantile hemangioma, promotes ligand-independent signal
120 ram per day for 6 months in the treatment of infantile hemangioma.
121 mportant for cellular growth and survival of infantile hemangioma.
122 owth factor-D is a target of itraconazole in infantile hemangioma.
123 ergic blocker that is first line therapy for infantile hemangioma.
124 fungal agent, can clinically improve or cure infantile hemangioma; however, the underlying molecular
125                                              Infantile hemangiomas (IH) are common tumors for which t
126                                              Infantile hemangiomas (IHs) are the most common benign t
127 Objectives: To describe the sequelae left by infantile hemangiomas after natural involution and to id
128                                              Infantile hemangiomas are benign tumors of vascular endo
129                                              Infantile hemangiomas are the most common benign tumors
130 nign vascular tumors that differ from common infantile hemangiomas in that they grow in utero and are
131                                  Importance: Infantile hemangiomas involute to some extent, but they
132 etrospective cohort study of images from 187 infantile hemangiomas that had not received systemic tre
133                              Most are benign infantile hemangiomas that typically regress by 5 years
134 opranolol has been used to treat complicated infantile hemangiomas, although data from randomized, co
135 ar malformations, juvenile angiofibromas and infantile hemangiomas.
136                                              Infantile hepatic hemangiomas exhibit a diverse phenotyp
137                              A proportion of infantile hepatic hemangiomas remain asymptomatic permit
138                   Two of the individuals had infantile hepatopathy with fibrosis and steatosis, leadi
139 ockout (Alpl (-/-)) mouse phenocopies severe infantile HPP, including profound skeletal and dental de
140 racteristic of the Alpl(-/-) model of severe infantile HPP.
141                                   Idiopathic infantile hypercalcemia (IIH) is characterized by severe
142 amino acid conversions associated with fatal infantile hypertrophic cardiomyopathy and the neurologic
143                                              Infantile hypertrophic pyloric stenosis (IHPS) is a diso
144  children with life-threatening perinatal or infantile hypophosphatasia showed 1 year safety and effi
145                   Patients with perinatal or infantile hypophosphatasia treated with asfotase alfa fo
146 r younger with life-threatening perinatal or infantile hypophosphatasia were recruited from ten hospi
147    Loss-of-function mutations of NALCN cause infantile hypotonia with psychomotor retardation and cha
148                             Symptoms include infantile hypotonia, global developmental delay, intelle
149  prenatal acetaminophen intake and increased infantile IgEs related to aeroallergens was statisticall
150 ansporter (hDAT, SLC6A3) cause a syndrome of infantile/juvenile dystonia and parkinsonism.
151               An infant presented with fatal infantile lactic acidosis and cardiomyopathy, and was fo
152 ciated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy
153 eta subunit (SCS A-beta) is linked to lethal infantile Leigh or leigh-like syndrome.
154  the ubiquitin adaptor protein PLAA cause an infantile-lethal neurodysfunction syndrome with seizures
155 ical outcomes to a more severe spectrum with infantile lethality (p.Val112Glu).
156  (ANM), a recessively inherited disease with infantile lethality.
157 mend NBAS analysis in individuals with acute infantile liver failure, especially if triggered by feve
158 associated pulmonary hypertension (PH) is an infantile lung disease characterized by aberrant angioge
159 ng the question of which mechanisms underlie infantile memories and amnesia.
160 rmation/maturation is necessary for creating infantile memories.
161 s both AMPA receptor response maturation and infantile memory, indicating that the synapse formation/
162                                              Infantile mice exposed to alpha-, gamma-, or CM-HBCD dem
163 ts have been characterized as causing severe infantile mitochondrial neurodegeneration.
164 ve disorder and the leading genetic cause of infantile mortality.
165 mutations in PDGFRB have been shown to cause infantile myofibromatosis, idiopathic basal ganglia calc
166 th mutations in CLN1 primarily manifest with infantile NCL (INCL or Haltia-Santavuori disease), which
167 underlie various types of NCLs, of which the infantile NCL (INCL) and congenital NCL (CNCL) are the m
168  for 52.3% of all disease causing alleles in infantile NCL, the most common of which worldwide is the
169 ow that, in an ovine model of a variant late-infantile NCL, there is abnormal expression of sleep hom
170 r DAP-component-encoding gene, as a cause of infantile nephronophthisis associated with central nervo
171  have been associated with disorders such as infantile neuroaxonal dystrophy, neurodegeneration with
172                       Krabbe's disease is an infantile neurodegenerative disease, which is affected b
173                           Here, we report an infantile neurodegenerative disorder associated with enh
174 nts from two unrelated families each with an infantile neurodegenerative disorder characterized by lo
175 nd blinding lysosomal storage disorder: late infantile neuronal ceroid lipofucinosis, also known as "
176 lmitoyl-protein thioesterase 1 (PPT1) causes infantile neuronal ceroid lipofuscinosis (CLN1), a pedia
177                  The Finnish variant of late infantile neuronal ceroid lipofuscinosis (CLN5 disease)
178                                              Infantile neuronal ceroid lipofuscinosis (INCL, Infantil
179                                              Infantile neuronal ceroid lipofuscinosis (INCL, or CLN1
180 neurologic features typical for variant late-infantile neuronal ceroid lipofuscinosis (vLINCL), a sev
181 tion of the novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis that we have ge
182 quences for the CLN2 gene implicated in late infantile neuronal ceroid lipofuscinosis with iodine-124
183                     The Finnish-variant late infantile neuronal ceroid lipofuscinosis, also known as
184                      Forty-two patients with infantile nystagmus (19 with albinism, 17 with idiopathi
185 herited disorder in humans, characterized by infantile nystagmus and foveal hypoplasia.
186      We imaged 81 eyes from 42 patients with infantile nystagmus of mean age 19.8 months (range, 0.9-
187  management of head position associated with infantile nystagmus syndrome (INS) when strabismus coexi
188 abnormal head position (AHP) associated with infantile nystagmus syndrome (INS).
189    This study was conducted on patients with infantile nystagmus syndrome and myopia equal to or more
190                         PRK in patients with infantile nystagmus syndrome and myopia improved monocul
191 tagmus (19 with albinism, 17 with idiopathic infantile nystagmus, and 6 with achromatopsia) were exam
192 de a high diagnostic yield for patients with infantile nystagmus, enabling access to disease specific
193  children affected by foveal hypoplasia with infantile nystagmus, following an autosomal recessive mo
194 rs (95% confidence interval [CI], 5.15-8.28) Infantile nystagmus, onset by 6 months, comprised 62 (87
195 of 93 age-similar children with unassociated infantile nystagmus.
196        Handheld OCT can predict future VA in infantile nystagmus.
197 occur almost as often as those with an early infantile onset (<3 months), and are thus more frequent
198                Patients presented with early infantile onset encephalopathy characterized by progress
199 yelination with spastic quadriplegia, and an infantile onset encephalopathy, suggesting multiple cell
200 nd in a single patient with a severe form of infantile onset encephalopathy.
201 eptic encephalopathy, characterized by early-infantile onset epilepsy and hypotonia with additional v
202 l loss of function, and with the neonatal or infantile onset epileptic encephalopathies due to KCNQ2
203                                          The infantile onset group had higher Charcot-Marie-Tooth dis
204 ng in a novel phenotype that includes severe infantile onset myoclonus, hypotonia, optic nerve abnorm
205                                  Clinically, infantile onset neurological regression with partial rec
206                                  Half of the infantile onset patients then required ambulation aids o
207                  We report two siblings with infantile onset seizures, severe developmental delay and
208  (MLC) is a genetic disease characterized by infantile onset white matter edema and delayed onset neu
209 isease is hypothesised to be between that of infantile-onset (ie, <6 years old) and adult-onset disea
210 -onset disease is typically more severe than infantile-onset and adult-onset disease, long-term morbi
211 n early-onset amyotrophic lateral sclerosis, infantile-onset ascending hereditary spastic paraplegia
212 emonstrate that FHF2 variants are a cause of infantile-onset developmental and epileptic encephalopat
213 f-function allele in UBA5 underlies a severe infantile-onset encephalopathy.
214 his gene has been previously associated with infantile-onset epilepsy syndromes in two other cohorts.
215 in-containing protein, is affected in a late infantile-onset form of NCL.
216 complex encoding gene, in an individual with infantile-onset generalized dystonia.
217 splantation (HSCT) is the only treatment for infantile-onset GLD; however, clinical outcomes of HSCT
218 lopmental syndrome characterized by profound infantile-onset hypotonia and developmental delay throug
219 ith a severe phenotype dominated by profound infantile-onset hypotonia and developmental delay.
220 nt stem cells (iPSCs) were generated from an infantile-onset IBD patient lacking a functional IL10RB
221                                              Infantile-onset inflammatory bowel disease (IO IBD) is a
222  neuron (SMN) protein triggers the oft-fatal infantile-onset motor neuron disorder, spinal muscular a
223  biallelic mutation in the PTRH2 gene causes infantile-onset multisystem disease with progressive mus
224                                 In parallel, infantile-onset mutant GALCs showed reduced trafficking
225 t siblings of consanguineous parents with an infantile-onset neurodegenerative disorder manifesting a
226                    Many GLD patients develop infantile-onset of progressive neurologic deterioration
227  SLC12A5 mutations in patients with a severe infantile-onset pharmacoresistant epilepsy syndrome, epi
228                                              Infantile-onset Pompe Disease (IOPD), caused by mutation
229                                              Infantile-onset Pompe disease is an autosomal recessive
230  reprogrammed fibroblasts from patients with infantile-onset Pompe disease to generate induced plurip
231 cted in dopamine transporter mutants causing infantile-onset rather than juvenile-onset disease.
232  neurodevelopmental delay and an intractable infantile-onset seizure disorder.
233 uNAc; sialic acid), in nine individuals with infantile-onset severe developmental delay and skeletal
234 ates meaningful change in clinical trials in infantile-onset SMA.
235                                              Infantile-onset spinal muscular atrophy (SMA) is the mos
236 and 12 mg dose equivalents) in patients with infantile-onset spinal muscular atrophy.
237 led, phase 3 clinical study of nusinersen in infantile-onset spinal muscular atrophy.
238 ved in the O-mannosylation pathway result in infantile-onset, severe developmental defects involving
239 , which results in muscle weakness and often infantile or childhood mortality.
240          Here, we study mutations that cause infantile or later-onset GLD, and show that GALC activit
241  unrelated hematopoietic transplantation for infantile osteopetrosis in 193 patients.
242 sease with severity ranging from progressive infantile paralysis and premature death (type I) to limi
243 ering a debilitating and often fatal form of infantile Parkinsonism known as AADC deficiency.
244 d in several DA-related disorders, including infantile parkinsonism, attention-deficit/hyperactivity
245 at included seizure onset in the prenatal or infantile period and severe verbal and ambulatory comorb
246 ast, all eyes (n = 112) of patients with non-infantile PH1 had a BCVA in the normal range (median, 20
247                         All eyes (n = 24) of infantile PH1 patients revealed severe retinal alteratio
248  or no ocular alterations are typical in non-infantile PH1 patients.
249                                              Infantile PH1 was diagnosed in 12 patients, and non-infa
250 le PH1 was diagnosed in 12 patients, and non-infantile PH1 was diagnosed in 56 patients (17 with end-
251 edict which infants are at high risk for the infantile phenotype while distinguishing other children
252 hthalmitis declined in both the neonatal and infantile population from 2007 through 2014.
253                   The rate of decline in the infantile population was 7% from 2007 through 2014.
254 lial cells of mouse hemangioma cell line and infantile primary hemangioma endothelial cell.
255                          In individuals with infantile regression and this pattern of MRI abnormaliti
256                                   Reversible infantile respiratory chain deficiency (RIRCD) is a rare
257                                              Infantile SCA7, which is often paternally transmitted, c
258                              Benign familial infantile seizures (BFIS), paroxysmal kinesigenic dyskin
259                         Variants observed in infantile seizures are predominantly missense, leading t
260 rum disorder (ASD), developmental delay, and infantile seizures.
261 h pontocerebellar hypoplasia (SMA-PCH) is an infantile SMA variant with additional manifestations, pa
262                  DNA methylation profiles of infantile sonic hedgehog-activated medulloblastoma (SHH-
263 preceding spasms, which was also observed in infantile spasm patients.
264     Comparisons were made to recordings from infantile spasm patients.
265                                              Infantile spasms (IS) and Lennox-Gastaut syndrome (LGS)
266 thies (EEs) Lennox-Gastaut syndrome (LGS) or infantile spasms (IS).
267 sistant epilepsy (OR = 0.23, p = 0.022), and infantile spasms (OR = 0, p < 0.001).
268 abnormalities, recurrent fever episodes, and infantile spasms .
269 lled infants who had a clinical diagnosis of infantile spasms and a hypsarrhythmic (or similar) EEG n
270 that p.Glu200Ala, previously associated with infantile spasms and microcephaly, is also pathogenic.
271  approved drug (Sabril) for the treatment of infantile spasms and refractory adult epilepsy.
272 are associated with intellectual disability, infantile spasms and seizures.
273                                              Infantile spasms are seizures associated with a severe e
274                                 The National Infantile Spasms Consortium established a multicenter, p
275                                              Infantile spasms constitutes a severe infantile epilepsy
276 ovel therapeutic target for the treatment of infantile spasms in DS.
277  an autism plus developmental syndrome after infantile spasms in others.
278 is necessary for the GABAB R agonist-induced infantile spasms phenotype in the Ts mouse and may repre
279 in Ts brain upon the GABAB R agonist-induced infantile spasms phenotype in the Ts mouse model of DS.
280 n-Q also rescued the GABAB R agonist-induced infantile spasms phenotype in Ts mutants.
281 is necessary for the GABAB R agonist-induced infantile spasms phenotype in Ts.
282 syndrome (DS) is exquisitely sensitive to an infantile spasms phenotype induced by gamma-aminobutyric
283  Ts mice rescued the GABAB R agonist-induced infantile spasms phenotype.
284  is significantly more effective at stopping infantile spasms than hormonal therapy alone.
285  is significantly more effective at stopping infantile spasms than hormonal therapy alone.
286 hat presented with cranial asymmetry, severe infantile spasms with hypsarrhythmia, and dysproportiona
287 Lennox-Gastaut syndrome, Dravet syndrome and infantile spasms with intellectual disability as well as
288 hould be considered as initial treatment for infantile spasms, including those with impaired developm
289 bility, cataracts, severe epilepsy including infantile spasms, irritability, failure to thrive, and s
290 2 gene are associated with schizophrenia and infantile spasms, respectively.
291 base enrolling infants with new diagnosis of infantile spasms.
292 lonic encephalopathy, Ohtahara syndrome, and infantile spasms.
293 gnature in patients with a recent history of infantile spasms.
294 first case to date of maternally transmitted infantile spinocerebellar ataxia type 7 (SCA7), in which
295 ardiomyopathy; the paradigmatic examples are infantile tafazzinopathies.
296 governs increased GnRH expression during the infantile-to-juvenile transition and that impairing micr
297 his report presents a 22-month-old girl with infantile type Sandhoff disease that was hospitalized fo
298 that GALC activity is significantly lower in infantile versus later-onset mutants when measured in th
299                                              Infantile wheezing is a common problem, but there are no
300                                     Although infantile wheezing is common, there is a paucity of evid

 
Page Top